|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
A
|
|
INDICATIONS:
|
|
|
|
SIDE EFFECTS:
|
|
Allergic reaction, specifically |
|
bronchospasm |
|
erythema |
|
fever |
|
general malaise |
|
skin rash or itching |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
|
|
ADULT DOSE:
|
|
Deficiency (prophylaxis)-Oral, amount based on normal daily recommended intakes:
Persons U.S. Canada
(mcg) (mcg)
Adolescent and adult males 150-400 150-220
Adolescent and adult females 150-400 145-190
Pregnant females 400 to 800 445-475
Breast-feeding females 260-800 245-275
Deficiency (treatment)-Treatment dose is individualized by prescriber based on severity of deficiency.
[Diagnostic aid (folate deficiency)] -Oral, 100 to 200 mcg (0.1 to 0.2 mg) a day for ten days plus low dietary folic acid and vitamin B . |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Deficiency (prophylaxis)-Oral, amount based on normal daily recommended intakes:
Persons U.S. Canada
(mcg) (mcg)
Infants and children 25- 50-80
Birth to 3 years of age
4 to 6 years of age 75-400 90
7 to 10 years of age 100-400 125-180
Deficiency (treatment)-Treatment dose is individualized by prescriber based on severity of deficiency. |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|